Uric acid as an additional risk factor in coronary artery disease in north Indians.

被引:0
作者
Chopra, Sunny [1 ,2 ]
Naithani, Manisha [1 ,2 ]
Mahajan, Mridula [1 ,2 ]
Bhagat, Sanjeev [3 ]
Singh, Santokh [1 ,2 ]
机构
[1] Govt Med Coll, Dept Biochem, Amritsar, Punjab, India
[2] Shri Guru Ram Rai Inst Med & Hlth Sci, Dehra Dun 248001, Uttar Pradesh, India
[3] Himalayan Inst Med Sci, Dept ENT, Dehra Dun, Uttar Pradesh, India
来源
BIOMEDICAL RESEARCH-INDIA | 2010年 / 21卷 / 04期
关键词
Coronary artery disease; plaque; uric acid; thrombosis;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Coronary artery disease (CAD) is a chronic inflammatory disease, characterized by disturbed cardiac functions due to imbalance between oxygen supply and demand. Atherosclerosis is the hallmark of CAD, occurring by deposition of yellow fibro fatty plaques known as atheroma which contains cholesterol, lipid and lipophages along with uric acid crystals. Elevated uric acid levels have been found to be associated with increased platelet aggregability and its activation thereby increasing the risk of coronary thrombosis. Hence, the present study was planned to explore the role of uric acid in causation of CAD and whether it act as an independent risk factor or in combination with other parameters. Present study included 50 CAD patients and equal number of age and sex matched control healthy volunteers. The study revealed a significant increase of serum uric acid levels in CAD patients as compared to healthy controls (p<0.001). Other studied biochemical profiles include serum Total Cholesterol (T-C), Low Density Lipoprotein Cholesterol (LDL-C) and High Density Lipoprotein Cholesterol (HDL-C), Very Low Density Cholesterol (VLDL-C) and Triacylglycerols (Tgs). T-C and LDL-C were found to be significantly elevated whereas HDL-C levels were observed to be significantly lower in CAD patients than controls. There were no significant changes in the levels of VLDL-C and serum triglycerides in patients in comparison to normal individuals. It was concluded that elevation in serum urate levels could be one of the possible risk factor responsible for CAD in conjunction with other risk factors.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 22 条
[1]  
ALLIAN CC, 1974, CLIN CHEM, V20, P470
[2]  
Andrew PS, 1996, HARRISONS PRINCIPLES, P1365
[3]   When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J].
Bagnati, M ;
Perugini, C ;
Cau, C ;
Bordone, R ;
Albano, E ;
Bellomo, G .
BIOCHEMICAL JOURNAL, 1999, 340 :143-152
[4]   MYOCARDIAL MALONDIALDEHYDE AND URIC-ACID RELEASE AFTER SHORT-LASTING CORONARY OCCLUSIONS DURING CORONARY ANGIOPLASTY - POTENTIAL MECHANISMS FOR FREE-RADICAL GENERATION [J].
DESCHEERDER, IK ;
VANDEKRAAY, AMM ;
LAMERS, JMJ ;
KOSTER, JF ;
DEJONG, JW ;
SERRUYS, PW .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) :392-395
[5]  
Ellsworth P, 1999, CORONARY HEART DIS W, VP3, P1
[6]   Allopurinol improves endothelial dysfunction in chronic heart failure [J].
Farquharson, CA ;
Butler, R ;
Hill, A ;
Belch, JJF ;
Struthers, AD .
CIRCULATION, 2002, 106 (02) :221-226
[7]  
FOSSATI P, 1980, CLIN CHEM, V26, P227
[8]   Troponin and outcomes [J].
Henrikson, CA ;
Chandra-Strobos, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1933-1934
[9]  
Hoieggen Aud, 2005, Tidsskr Nor Laegeforen, V125, P1330
[10]   Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease [J].
Johnson, RJ ;
Kivlighn, SD ;
Kim, YG ;
Suga, S ;
Fogo, AB .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (02) :225-234